MRE for inflammatory vs fibrotic strictures

What is known

• Guideline and reviews state most cross-sectional imaging, including CT and MR enterography, has limited ability to discriminate fibrotic from inflammatory strictures. ¹
• MRE remains the best upfront modality to characterize strictures; novel MRI protocols (diffusion-weighted, delayed/magnetization-transfer contrast) are being developed specifically to differentiate fibrosis from inflammation. ^2,3
• MRE stricture-detection accuracy is high (sensitivity 75–100%, specificity 91–96%) and it is the preferred method for fuller characterization without radiation. ^4–6
• Strictures usually contain a coexisting mixture of inflammation, fibrosis, and smooth-muscle expansion, which underlies the difficulty of clean discrimination. ^2,3

What is unknown / caveats

• Some reviews report MR/US can differentiate active inflammation from fibrosis via vascularity/enhancement ^7,8, while guideline-level sources call this discrimination unreliable ^1,6
• The high MRE accuracy figures are for stricture DETECTION vs histopathology, not for isolating the fibrotic component
• Promising discriminators (contrast-enhanced/elastography US, DWI, delayed-enhancement MRI, PET/MR) are largely early-stage and not validated at scale
• Significant heterogeneity in stricture definitions and histopathologic scoring limits cross-study comparison ^4,6
• No validated MRE threshold or sequence reliably quantifies fibrosis versus inflammation in the individual mixed stricture.

References

1. Fousekis FS, Mitselos IV, Tepelenis K, Pappas-Gogos G, Katsanos KH, Lianos GD, Frattini F, Vlachos K, Christodoulou DK. Medical, Endoscopic and Surgical Management of Stricturing Crohn's Disease: Current Clinical Practice. J Clin Med. 2022;11(9). PMID: 35566492.

2. Elford AT, Ardalan Z, Simkin P, Christensen B. Comprehensive review and update of stricturing Crohn's disease. Indian J Gastroenterol. 2024;43(1):64-77. PMID: 38277070.

3. Yuan G, He Y, Cao QH, Tang MM, Xie ZL, Qiu Y, Zeng ZR, Peng S, Chen MH. Visceral adipose volume is correlated with surgical tissue fibrosis in Crohn's disease of the small bowel. Gastroenterol Rep (Oxf). 2022;10:goac044. PMID: 36042948.

4. [No authors listed]. Natural history, diagnosis and treatment approach to fibrostenosing Crohn's disease. United European Gastroenterol J. 2020;8(3):263-270. PMID: 32213020.

5. Chan WPW, Mourad F, Leong RW. Crohn's disease associated strictures. J Gastroenterol Hepatol. 2018;33(5):998-1008. PMID: 29427364.

6. [No authors listed]. Prevention and Treatment of Stricturing Crohn's Disease - Perspectives and Challenges. Expert Rev Gastroenterol Hepatol. 2021;15(4):401-411. PMID: 33225766.

7. Malgras B, Pautrat K, Dray X, Pasquier P, Valleur P, Pocard M, Soyer P. Multidisciplinary management of gastrointestinal fibrotic stenosis in Crohn's disease. Dig Dis Sci. 2015;60(5):1152-68. PMID: 25381203.

8. Gasparetto M, Angriman I, Guariso G. The multidisciplinary health care team in the management of stenosis in Crohn's disease. J Multidiscip Healthc. 2015;8:167-79. PMID: 25878504.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.